Olympus America

Press Center

Olympus Acquires Advalytix

European purchase adds cutting-edge technologies for future growth worldwide

Melville, NY, July 26, 2005 - Olympus Life and Material Science Europa GmbH (Hamburg, Germany), a subsidiary of the Olympus Corporation, has acquired the privately held European microfluidics company Advalytix AG (Brunnthal, Germany). With this move, Olympus demonstrates its commitment to its fast-growing in vitro diagnostics and life sciences businesses. The acquisition provides Olympus with key technologies to maximize growth in innovative analytical systems.

"The acquisition of Advalytix represents great opportunities for Olympus worldwide," said Stephen Wasserman, Group Vice President, Diagnostic Systems Group, Olympus America Inc. "It positions Olympus at the very forefront of the latest technological developments in the life sciences, puts us at the center of business opportunities in this rapidly expanding field, and helps us sustain our double digit growth."

Olympus will apply Advalytix's technology to enhance analytical reactions on diagnostic instrumentation and to expand into new areas such as Single-Cell PCR (Polymerase Chain Reaction) or Lab-on-a-Chip in routine diagnostics. Microfluidics, used to manipulate liquids in the submicroliter range, is a key technology for both in vitro diagnostics and molecular biology research. By miniaturizing liquid volumes, scarce samples and expensive reagents are conserved. Advalytix's proprietary technology has been commercialized with the SlideBoosterâ„¢ hybridization and AdvaWashâ„¢ washing stations, targeted at the microarray market. The company is also developing products and protocols for the genetic analysis of single cells.

About Olympus Diagnostic Systems Group
Olympus Diagnostic Systems Group provides innovative solutions that meet the high productivity demands of hospitals, integrated healthcare delivery networks, reference labs, blood banks and pharmaceutical labs. Olympus offers the broadest standardized line of random access chemistry-immuno analyzers, along with lab automation systems, comprehensive patient safety systems, blood bank analyzers and reagents. Olympus solutions save laboratories time, enhance patient safety, maximize productivity, and deliver fast, reliable results.

About Olympus
Olympus is a precision technology leader, designing and delivering innovative solutions in healthcare and consumer electronics worldwide.

Olympus works collaboratively with its customers and its parent company, Tokyo-based Olympus Corporation, to leverage R&D investment in precision technology and manufacturing processes across diverse business lines. These include:

  • Gastrointestinal endoscopes, accessories, and minimally invasive surgical products;
  • Advanced clinical and research microscopes;
  • Lab automation systems, chemistry-immuno and blood bank analyzers and reagents; and
  • Digital and film cameras, and digital voice recorders.

In the U. S. and Canada, Olympus serves healthcare, scientific and commercial laboratory markets with integrated product solutions and financial, educational and consulting services that help customers efficiently, reliably, safely, and easily achieve superior results. Olympus is the leader in gastrointestinal endoscopy and clinical and educational microscopes. The company's market-leading consumer electronics business spans North and South America. For more information, visit www.olympusamerica.com.